Zoetis
ZTS
A$252.85
Share price
0.34%
Change (1 day)
-6.93%
Change (1 year)
Categories
Zoetis (ZTS) - Cash on Hand
Cash on Hand as of March 2025 : A$2.63 Billion
According to Zoetis's latest financial reports the company has A$2.63 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Zoetis - Cash on Hand chart (from 2011 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | A$3.19 B | 6.63% |
| 2023-12-31 | A$2.99 B | -43.06% |
| 2022-12-31 | A$5.25 B | 9.44% |
| 2021-12-31 | A$4.80 B | 2.53% |
| 2020-12-31 | A$4.68 B | 69.76% |
| 2019-12-31 | A$2.75 B | 14.62% |
| 2018-12-31 | A$2.40 B | 20.17% |
| 2017-12-31 | A$2.00 B | 98.63% |
| 2016-12-31 | A$1.00 B | -36.33% |
| 2015-12-31 | A$1.58 B | 46.99% |
| 2014-12-31 | A$1.07 B | 57.59% |
| 2013-12-31 | A$0.68 B | 124.19% |
| 2012-12-31 | A$0.30 B | 295.92% |
| 2011-12-31 | A$77.04 M | 24.23% |
| 2010-12-31 | A$62.02 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | A$4.93 B | 87.14% | 🇺🇸 USA |
 Merck MRK | A$14.12 B | 436.20% | 🇺🇸 USA |
 Pfizer PFE | A$26.50 B | 906.16% | 🇺🇸 USA |
 Phibro Animal Health
PAHC | A$0.10 B | -95.91% | 🇺🇸 USA |
 Kindred Biosciences
KIN | N/A | N/A | 🇺🇸 USA |
 Heska Corporation
HSKA | A$0.19 B | -92.72% | 🇺🇸 USA |
 Sanofi SNY | A$13.24 B | 402.58% | 🇫🇷 France |